Calafiore Massimo

President & CEO

Orthofix Medical Inc.

US, Lewisville [HQ]

CIK 1828602

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

141,084

Price per Share :

$17.95

Equivalence :

$2,532,457.80

Transaction History

A

Form 4

141,084 Shares After Transaction

Value : $1,875,006.36

$1,875,006.36

Transaction Date : 01/08/24
- Footnotes
- Form 4
Footnotes:
#1 The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
S

Form 4

133,354 Shares After Transaction

Value : $2,244,347.82

Sold $169,612.74

Transaction Date : 01/10/25
- Footnotes
- Form 4
Footnotes:
#1 Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

#3 Includes 94,057 previously reported restricted stock units.

#4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive.
S

Form 4

124,151 Shares After Transaction

Value : $2,127,948.14

Sold $157,739.42

Transaction Date : 01/13/25
- Footnotes
- Form 4
Footnotes:
#1 Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.

#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.525 to $17.08, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.

#3 Includes 94,057 previously reported restricted stock units.

#4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.27, inclusive.